Results 211 to 220 of about 31,184 (259)
Some of the next articles are maybe not open access.

Intravitreal Injection Technique

Seminars in Ophthalmology, 2011
As the intravitreal injection of therapeutic medication plays an increasingly large role in ophthalmology, its implementation continues to be modified and refined. Variations in injection technique are discussed, and the authors combine their clinical and research experience with a review of the literature to propose a recommended intravitreal ...
Rishi R, Doshi   +2 more
openaire   +2 more sources

Intravitreal Injection of Piperacillin

Ophthalmic Surgery, Lasers and Imaging Retina, 1989
ABSTRACT Piperacillin was injected into the vitreous body of rabbit eyes to evaluate its suitability for intraocular injection and its toxicity on intraocular tissues. Doses ranged from 50 µg to 3,000 µg. Toxicity was determined through histology and electroretinograms by comparing the piperacillin-injected eyes with eyes injected with ...
H C, Semple, J C, Liu, G A, Peyman
openaire   +2 more sources

Intravitreal Injections in the Ovine Eye

Journal of Visualized Experiments, 2022
There are several methods for the delivery of therapeutic agents to the retina, including intravitreal (IVT), subretinal, suprachoroidal, periocular, or topical administration. IVT drug delivery involves an injection into the vitreous humor of the eye, a gelatinous substance that fills the posterior chamber of the eye and maintains the shape of the eye
Murray, Samantha, Mitchell, Nadia
openaire   +3 more sources

Complications of intravitreal injections: 2022

Current Opinion in Ophthalmology, 2022
Purpose of review This review highlights the complications of both intravitreal injection procedure as well as different intravitreal medications including antivascular endothelial growth factors, antibiotics, antivirals, antifungals, methotrexate, and steroids.
Dillan, Patel   +3 more
openaire   +2 more sources

INTRAVITREAL INJECTION OF THERAPEUTIC AGENTS

Retina, 2009
Intravitreal injection (IVI) with administration of various pharmacological agents is a mainstay of treatment in ophthalmology for endopthalmitis, viral retinitis, age-related macular degeneration, cystoid macular edema, diabetic retinopathy, uveitis, vascular occlusions, and retinal detachment.
Gholam A, Peyman   +2 more
openaire   +2 more sources

OUTCOMES OF AN INTRAVITREAL INJECTION CLINIC

Retina, 2017
Purpose: To examine the safety outcomes of an intravitreal injection-only clinic where patients needing long-term anti-vascular endothelial growth factor therapy are treated with injections at a predetermined interval for a set number of injections without an accompanying clinic visit. Methods:
Elizabeth A, Atchison   +4 more
openaire   +2 more sources

EVOLVING GUIDELINES FOR INTRAVITREOUS INJECTIONS

Retina, 2004
Intravitreous (i.v.t.) injection is increasingly being incorporated into the management of ocular diseases. While only fomivirsen sodium (Vitravene) is currently approved by the Food and Drug Administration as an i.v.t. injection, the number of approved i.v.t.
Lloyd P, Aiello   +13 more
openaire   +2 more sources

Endophthalmitis after intravitreal injections

Expert Opinion on Pharmacotherapy, 2009
Endophthalmitis following intravitreal injection is an infrequent but serious clinical problem. Infectious endophthalmitis must be differentiated from noninfectious inflammation. Depending on the series, the risk of endophthalmitis is very low. The use of a standardized injection protocol can reduce the risk of infection.
Stephen G, Schwartz   +2 more
openaire   +2 more sources

Inadvertent Intravitreal Gentamicin Injection

European Journal of Ophthalmology, 2002
Purpose To describe the management and consequences of an accidental injection of gentamicin in the vitreous. Methods A retinal detachment developed in a 70-year-old male.
Z, Burgansky, T, Rock, E, Bartov
openaire   +2 more sources

Intravitreal Injection of Octreotide Acetate

Journal of Ocular Pharmacology and Therapeutics, 1997
This study was conducted to determine the feasibility of injecting the somatostatin analogue, octreotide acetate (OA), into the vitreous cavity. Previous work suggests that octreotide effectively inhibits angiogenesis in vitro, thus its use in vivo may slow the progression of proliferative eye disease.
J E, Robertson   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy